论文部分内容阅读
目的观察小儿哮喘急性发作期给予布地奈德雾化吸入治疗的疗效与安全性。方法以我院2016年1月~2016年12月期间儿科接诊的80例哮喘急性发作患儿进行对比分析,采用平行抽样法将其分为对照组与观察组各40例,所有患者确诊后均在临床医生指导下给予对症支持治疗,观察组在此基础上雾化吸入布地奈德(2次/d,10~20min/次,连用7d),并在治疗后对两组治疗效果与药物不良反应发生情况进行对比分析。结果 1治疗后,观察组临床总有效率为95%,明显高于对照组,具有统计学意义,P<0.05。2治疗期间,观察组的不良反应发生率为7.5%;对照组的不良反应发生率为15%,略高于对照组,但不具有统计学意义,P>0.05。结论在小儿哮喘急性发作治疗中,结合常规对症治疗与布地奈德雾化吸入,可以有效提高治疗效果,而且药物不良反应少,值得推广。
Objective To observe the efficacy and safety of inhaled budesonide inhalation in the acute episode of pediatric asthma. Methods 80 cases of pediatric acute asthma attack in our hospital from January 2016 to December 2016 were compared and analyzed by parallel sampling and divided into control group and observation group of 40 cases. All patients were diagnosed All patients were given symptomatic and supportive treatment under the guidance of clinicians. On the basis of this, the observation group inhaled budesonide (2 times / d, 10 ~ 20min / time, once every 7 days), and after treatment, Adverse reactions occurred comparative analysis. Results 1 After treatment, the clinical observation group total effective rate was 95%, significantly higher than the control group, with statistical significance, P <0.05.2 during treatment, the adverse reaction rate was 7.5% in the observation group; adverse reactions in the control group The incidence was 15%, slightly higher than the control group, but not statistically significant, P> 0.05. Conclusion In the treatment of acute exacerbation of pediatric asthma, combined with routine symptomatic treatment and inhalation of budesonide can effectively improve the therapeutic effect, and the adverse drug reactions are few and worth promoting.